Latest News & Features
Americas
A Johnson & Johnson company, Janssen Pharmaceuticals, is seeking a court order blocking Mylan from making copies of its schizophrenia treatment, Invega Trinza, until its patent expires in 2036. 29 September 2020
article
Join us for an interview with Professor Timo Minssen, Director of the Center for Advanced Studies in Biomedical Innovation Law at the University of Copenhagen, as we discuss the current state of IP law in the life sciences; regulating medical AI and big data; and the latest research projects from The University of Copenhagen. 29 September 2020
Americas
The US Court of Appeals for the Federal Circuit has sided with EMD Serono and Pfizer over the invalidation of a multiple sclerosis drug patent, in a defeat for biotech company Biogen. 29 September 2020
Americas
MSD subsidiary Idenix has urged the US Supreme Court to review the overturning of a record $2.5 billion verdict against Gilead Sciences. 28 September 2020
Americas
The US Patent Trial and Appeal Board has invalidated parts of an AbbVie patent covering blood disease drug Imbruvica. 25 September 2020
article
We are delighted to have Justice Birss join our editor-in-chief, Peter Scott, to discuss the UK patent landscape and revisit some of the key judgements of the past few years, and well as to get thoughts on the future of IP in the UK post-Brexit and beyond. 24 September 2020
Americas
Danish biotech Genmab has commenced binding arbitration of two matters with Janssen Biotech, a Johnson & Johnson company, over royalty payments for a cancer drug. 24 September 2020
Americas
ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development. 23 September 2020
Americas
Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement. 23 September 2020
Americas
Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago. 23 September 2020